Key result
Ticlopidine pretreatment in a mini-pig model of heart failure reduced infarct size to 9.5% of the left ventricle compared to 20% in control animals.
Why the study?
Does ticlopidine reduce infarct size and acute haemodynamic changes in a mini-pig model of heart failure induced by coronary embolisation?
Does ticlopidine reduce infarct size and acute haemodynamic changes in a mini-pig model of heart failure induced by coronary embolisation?
Ticlopidine pretreatment significantly reduced infarct size and attenuated acute haemodynamic changes in a mini-pig model of heart failure induced by coronary embolisation.
Answers are grounded in this paper and cite their sources.
Supports ticlopidine exploration in ischemic HF models; leaves open translation to human practice.
A clinically relevant model of heart failure has been developed in chronically instrumented mini-pigs by injecting Sephadex beads into the left main or circumflex coronary arteries under fluoroscopic control. In six control animals, left atrial pressure (LAP) increased from 10 +/- 2 to 19 +/- 2 mmHg (p less than 0.01) and remained elevated for 3 days. Heart rate increased by 26 beats X min-1 (p less than 0.05) and diastolic pressure fell after 24 h but recovered over the next 48 h. In six animals treated with ticlopidine (50 mg X kg-1 p.o.) for four days prior to embolisation, the acute haemodynamic changes were less in the first day but similar to control after 3 days. Infarct size was approximately 20% of the left ventricle in control animals and 9.5% in the treated group (p less than 0.01). ADP-induced platelet activity was reduced in the treated animals suggesting that coronary occlusion followed both physical occlusion by the beads and later development of platelet thrombi.
No takes yet. Share an insight, caveat, or question.
NUTTALL et al. (1985) studied heart failure (n=12). ticlopidine vs. control was evaluated on Infarct size (% of left ventricle) (p=<0.01). Ticlopidine pretreatment in a mini-pig model of heart failure reduced infarct size to 9.5% of the left ventricle compared to 20% in control animals.
Synapse has enriched 10 related papers. Consider them for comparative context: